Clinical trial
CHOOSE: Telithromycin, Acute Bacterial Sinusitis
NCT00174694 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00174694 |
|---|---|
| Title | CHOOSE : Telithromycin, Acute Bacterial Sinusitis |
| Official title | A Prospective, Randomized, Open-label, Active-controlled Study in Adult Subjects With Acute Bacterial Sinusitis Comparing the Clinical Efficacy of Telithromycin (KETEK®) 800 mg Once a Day for 5 Days Versus Amoxicillin-clavulanic Acid (AUGMENTIN®) 875/125 mg Twice a Day for 10 Days |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Sinusitis |
| Intervention type | Drug |
| Interventions | Telithromycin |
| Enrollment | 298 |
| Start date | Nov 1, 2004 |
| Primary completion | Dec 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | Sep 25, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: